Expression of the CSC markers AF, EpCAM, and EpCAM/AF in patients with colorectal cancer with or without relapse. A–C, Box plots according to AF, EpCAM, and EpCAM/AF expression levels in patients with or without relapse. D–F, Box plots according to AF, EpCAM, and EpCAM/AF expression levels including LN involvement. No statistically significant differences were found between groups.
No takes yet. Share an insight, caveat, or question.
Alcalá et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: